WILLIAMS DOUGLAS E — SEC Form 4 filings

SEC reporting owner CIK 1184847. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-03-08 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Climb Bio, Inc. (CLYM)Director45
Camp4 Therapeutics Corp (CAMP)Director22
Sana Biotechnology, Inc. (SANA)EVP & President, R&D12

Form 4 filings — WILLIAMS DOUGLAS E

FiledFormIssuerReported transactionsSource
2026-06-124Camp4 Therapeutics Corp (CAMP)Grant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-084Climb Bio, Inc. (CLYM)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-06-054Climb Bio, Inc. (CLYM)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-04-014Climb Bio, Inc. (CLYM)Grant/award (A): 78,873 (derivative) @ $0EDGAR
2025-03-194Camp4 Therapeutics Corp (CAMP)Grant/award (A): 17,787 (derivative) @ $0EDGAR
2024-11-124Climb Bio, Inc. (CLYM)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 6,291 (derivative) @ $0EDGAR
2024-03-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 67,083 (derivative) @ $0 · Grant/award (A): 301,875 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184847 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →